Resin Infiltration Versus Microabrasion With CPP-ACP for Fluorotic White Spot Lesions
Resin Infiltration Versus Microabrasion Combined With CPP-ACP for Masking Fluorotic Anterior White Spot Lesions: A 6-Month Randomized Controlled Clinical Trial
Dental fluorosis can cause visible chalky-white spots on the front teeth. These white spot lesions may affect dental appearance even when the tooth surface is intact.
This randomized clinical trial compared two minimally invasive approaches for masking fluorotic white spot lesions on permanent anterior teeth. Eligible teeth were randomly assigned to receive either resin infiltration or enamel microabrasion followed by application of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP).
The main outcomes were the color difference between the white spot lesion and the surrounding sound enamel and the proportion of the visible tooth surface occupied by the lesion. These outcomes were evaluated from standardized clinical photographs before treatment, after treatment, and during follow-up through 6 months.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This was a prospective, controlled, two-arm randomized clinical trial conducted at the Dental Clinic of the University of Medicine and Pharmacy Hospital, Hue University, Vietnam, between June 2023 and June 2025. Patients with fluorotic white spot lesions on permanent anterior teeth were enrolled. Eligible lesions were shallow, chalky-white enamel opacities confined to the outer enamel and clinically consistent with dental fluorosis.
Randomization was performed at the tooth level. A total of 60 eligible teeth were allocated in a 1:1 ratio to one of two treatment groups: resin infiltration or enamel microabrasion followed by CPP-ACP application. Allocation was concealed using sequentially numbered, opaque, sealed envelopes. All procedures were performed by one operator under standardized clinical conditions.
In the resin-infiltration group, the lesion surface was treated with 15% hydrochloric acid, rinsed and dried, followed by ethanol application. A low-viscosity resin infiltrant was then applied and light-cured according to the study protocol.
In the microabrasion plus CPP-ACP group, the labial enamel surface was treated with a hydrochloric-acid and silicon-carbide microabrasion material using repeated polishing cycles. CPP-ACP paste was then applied to the treated surface for 5 minutes.
Two co-primary outcomes were evaluated from standardized clinical photographs: the color difference between the lesion and adjacent sound enamel, expressed as ΔE in the CIELab* color space, and the lesion-area ratio, expressed as the percentage of the visible labial tooth surface occupied by the lesion. Images were obtained under reproducible lighting, magnification, camera-positioning, and patient-positioning conditions.
Color measurements were obtained from sampled points within the lesion and adjacent sound enamel. Lesion area and total labial-surface area were outlined and measured using image-analysis software. Outcome assessments were performed by an independent examiner who was blinded to treatment allocation using coded image files. Measurements were obtained before treatment and at prespecified post-treatment and follow-up assessments through 6 months.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Huế, Vietnam, 530000
- Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Patients presenting with fluorotic white spot lesions on permanent anterior teeth.
- Shallow fluorotic white spot lesions confined to the outer enamel.
- Chalky-white lesions with a clear border from adjacent sound enamel.
- Lesions appearing bright on oblique visual inspection and mildly dim under diagnostic transillumination.
- Clinical diagnosis of dental fluorosis based on the characteristic bilateral, symmetrical, and diffuse distribution of enamel opacities.
- Willingness to participate in the study and comply with treatment and follow-up visits.
Exclusion Criteria:
- Deep subsurface enamel lesions.
- Lesions consistent with molar-incisor hypomineralization.
- Lesions with yellow or brown discoloration.
- Known allergy or hypersensitivity to ICON, Opalustre, Tooth Mousse, or their components.
- Inability to tolerate rubber-dam isolation.
- Poor oral hygiene.
- Inability or unwillingness to attend the scheduled follow-up assessments.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Resin Infiltration
Eligible fluorotic white spot lesions were treated with resin infiltration using the ICON Vestibular Kit.
After rubber-dam isolation, 15% hydrochloric acid was applied for 120 seconds, rinsed for 30 seconds, and air-dried.
Ethanol was applied for 30 seconds, and the etching step was repeated if needed.
The resin infiltrant was then applied, excess material was removed, and the surface was light-cured according to the study protocol.
|
After tooth cleaning and rubber-dam isolation, 15% hydrochloric acid was applied to the fluorotic white spot lesion for 120 seconds, rinsed for 30 seconds, and air-dried.
Ethanol was applied for 30 seconds to assess lesion masking, and the etching step was repeated if the lesion remained visible.
A low-viscosity resin infiltrant was applied for 180 seconds, excess material was removed, and the surface was light-cured for 40 seconds.
A second application was performed for 60 seconds and light-cured for an additional 40 seconds.
|
|
Aktiv komparator: Microabrasion Plus CPP-ACP
Eligible fluorotic white spot lesions were treated with enamel microabrasion followed by CPP-ACP application.
Opalustre containing 6.6% hydrochloric acid and silicon carbide particles was applied to the labial enamel surface and polished with a rubber cup at approximately 500 rpm for 60 seconds.
The procedure was repeated for five cycles, followed by application of CPP-ACP gel for 5 minutes.
|
After tooth cleaning and rubber-dam isolation, an enamel microabrasion material containing 6.6% hydrochloric acid and silicon carbide particles was applied to the labial enamel surface and polished with a rubber cup at approximately 500 rpm for 60 seconds.
The surface was rinsed, and the procedure was repeated for five cycles.
CPP-ACP paste was then applied to the treated enamel surface for 5 minutes.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
CIELAB Color Difference Between the Fluorotic Lesion and Adjacent Sound Enamel
Tidsramme: At baseline and four post-treatment assessments through 6 months (T0-T4)
|
The color difference between the fluorotic white spot lesion and adjacent sound enamel was measured from standardized clinical photographs in the CIELab* color space.
Mean L*, a*, and b* values were obtained from three points within the lesion and three points on adjacent sound enamel located 2 mm from the lesion margin.
Color difference was calculated as ΔE = [(ΔL*)² + (Δa*)² + (Δb*)²]¹ᐟ².
Lower ΔE values indicate better color matching and lesion masking.
A ΔE value below 3.7 was considered not clinically perceptible to the naked eye.
|
At baseline and four post-treatment assessments through 6 months (T0-T4)
|
|
Fluorotic Lesion-Area Ratio on the Labial Tooth Surface
Tidsramme: At baseline and four post-treatment assessments through 6 months (T0-T4)
|
The fluorotic white spot lesion and the visible labial tooth surface were outlined on standardized clinical photographs and measured using ImageJ.
The lesion-area ratio was calculated as R (%) = (lesion area / total visible labial surface area) × 100.
Scores range from 0% to 100%, with lower values indicating a smaller visible lesion area and better lesion masking.
|
At baseline and four post-treatment assessments through 6 months (T0-T4)
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Van Nhat Thang Le, DDS PhD, Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Dental emalje hypomineralisering
- Udviklingsdefekter af emalje
- Stomatognatiske sygdomme
- Tandsygdomme
- Stomatognatiske systemabnormiteter
- Medfødte abnormiteter
- Tandabnormiteter
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Fluorose, Dental
- Tandlæge
- Estetik, tandlæge
- caseinfosfopeptid-amorf calciumfosfat nanokompleks
- Emalje Mikroslibning
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- H2023/124
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .